Loading
Latest filing published 13 Sept 2019 for Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.), €7,123.
No signal scores available.
Frank R. Oakes is a declared insider of Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.), with filings sourced from SEDI. The record holds 2 filings, for trades running from 7 June 2019 to 11 September 2019.
Sales make up the whole of the open-market record (1 sale, €7,123).
The newest entry dates from 13 September 2019: an open-market sale of €7,123, in Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.). Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations